World Journal of Nuclear Medicine

ORIGINAL ARTICLE
Year
: 2014  |  Volume : 13  |  Issue : 1  |  Page : 28--33

Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent


Samaneh Zolghadri, Amir Reza Jalilian, Hassan Yousefnia, Ali Bahrami-Samani, Mohammad Ghannadi-Maragheh 
 Radiopharmacy Research Group, Radiation Application Research School, Nuclear Science and Technology Research Institute, P.O.Box:14395-836, Tehran, Iran

Correspondence Address:
Dr. Amir Reza Jalilian
Radiopharmaceutical Research and Development Laboratory, Nuclear Science and Technology Research Institute, Tehran
Iran




How to cite this article:
Zolghadri S, Jalilian AR, Yousefnia H, Bahrami-Samani A, Ghannadi-Maragheh M. Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent.World J Nucl Med 2014;13:28-33


How to cite this URL:
Zolghadri S, Jalilian AR, Yousefnia H, Bahrami-Samani A, Ghannadi-Maragheh M. Development of 166 Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent. World J Nucl Med [serial online] 2014 [cited 2020 Feb 25 ];13:28-33
Available from: http://www.wjnm.org/text.asp?2014/13/1/28/138571


Full Text

This article is being retracted on the grounds of duplicity of content.

[INLINE:1]